July 22 Could Ignite a Financial Nightmare

He said “a major reckoning is coming” 3 months before 2025’s crash… his work pointed to the Covid crash 25 days before stocks bottomed… and his firm spends $8 million a year in search of the biggest declines in the stock market. Now – one man has a chilling warning for the financial system on July 22.

Tue, July 22 at 10:00AM ET
 
 
 
 

Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors Send Shares Rocketing

Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company.

Robinhood IPO Roadshow: What Potential HOOD Investors Need to Watch on July 24

Robinhood is holding a roadshow livestream this weekend to go over details of the company's upcoming initial public offering (IPO).

NURO Stock: The ‘Breakthrough’ News Rocketing NeuroMetrix Shares Higher Today

NeuroMetrix (NURO) stock is surging higher on Tuesday after getting "Breakthrough Device Designation" from the FDA for Quell.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

What will the stock market do today? It'll watch in awe as Bezos flies to the edge of space, and digital currency will continue its woes.

PTON Stock: The UNH Deal Giving Peloton Shares a Jump Today

Peloton (PTON) stock is pushing higher today thanks to a deal with UnitedHealth Group (UNH) that will have the two working together.

ARDX Stock: Disastrous FDA News Sends Ardelyx Shares Plummeting

News from the FDA is not good for ARDX stock. Investor reaction has been swift and harsh, as is often the case with risky biotech stocks.

Crypto Crash: Where Experts Think Bitcoin Prices Are Headed Next

Concerns about a crypto crash are rising on social media following Bitcoin (BTC) dropping below the $30,000 mark late last night.

Nvidia Stock Split 2021: What NVDA Investors Should Know as the 4-for-1 Split Goes Into Effect

Nvidia shares are set to trade on a post-split basis today, after management completed a 4-for-1 move to make NVDA stock more affordable.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning! We're getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

What did the stock market do today? Well, it lost big, as investors become slightly more shaken up over the delta variant and Covid concerns.

AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today

Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum.

PTON Stock: Why Peloton Stock Is Riding Higher Today

Today, investors in PTON stock are seeing gains of 6% as the company announced its move into the video game space.

HOOD Stock: 7 Things You Need to Know About the Upcoming Robinhood IPO

Robinhood will be making its way to trading floors under the 'HOOD' stock ticker. Here's what you need to know about the upcoming IPO.

The Next Lucid Motors/CCIV? 7 Things to Know About GGPI’s Polestar SPAC Merger Talks

Discussion around whether the potential Polestar/GGPI SPAC merger could be the next Lucid Motors/CCIV has investors excited today.

NRXP Stock: The ‘Cykotine Storm’ Drug News Sending NRx Pharma Shares Soaring

Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial.

FIVN, ZM Stock: What Zoom Investors Should Know About the Huge Five9 Acquisition

Investors in ZM stock are seeing red today, after Zoom announced a massive, multi-billion-dollar acquisition. Here's what to know.

CYTK Stock Flies High on Exciting Drug Trial Results

CYTK stock is being boosted by bullish biopharma buyers today. The company is reporting with optimism regarding its newest HCM treatment.

Market Outlook: What Stocks Are Down Today?

We're at the halfway point for Monday and now is a good time to check in with a market outlook of what stocks are doing today.

Outbrain IPO: 13 Things for Potential Investors to Know About Outbrain and OB Stock

Outbrain is moving forward with its initial public offering (IPO) plans and we've got all the details traders need to know about it!